Considering the above-mentioned direct role for TNF in atherosclerosis, we also evaluated the presence of potential drug-specific effects by categorizing RA subjects into those with either stable remission with anti-TNF therapy or stable remission without anti-TNF therapy (but with disease-modifying antirheumatic drugs (DMARDs). Here, TNF is linked to atherosclerosis.